UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Clinical research in cardiology, ISSN 1861-0684, 1/2017, Volume 106, Issue 1, pp. 1 - 9
Clinical trials as topic | Pragmatic clinical trials as topic | Medicine & Public Health | Cardiology | Cardiovascular diseases | Electronic health records | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Comparative Effectiveness Research - methods | Data Accuracy | Data Mining - ethics | Electronic Health Records - ethics | Humans | Access to Information | Cardiovascular Diseases - therapy | Systems Integration | Comparative Effectiveness Research - ethics | Confidentiality | Cardiovascular Diseases - epidemiology | Clinical Trials as Topic - ethics | Clinical Trials as Topic - methods | Medical Record Linkage | Research Design | Cardiovascular Diseases - diagnosis | Clinical trials | Medicine, Experimental | Medical records | Medical research | Electronic records | Index Medicus | Review
Journal Article
Diabetes care, ISSN 0149-5992, 09/2018, Volume 41, Issue 9, pp. 1844 - 1853
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Hypoglycemia - epidemiology | Metformin - therapeutic use | Hypoglycemic Agents - economics | Primary Health Care - statistics & numerical data | Humans | Middle Aged | Diabetes Mellitus, Type 2 - economics | Male | Sulfonylurea Compounds - economics | Diabetes Mellitus, Type 2 - epidemiology | Metformin - economics | Thiazolidinediones - therapeutic use | Aged, 80 and over | Adult | Female | Hypoglycemia - economics | Hypoglycemia - chemically induced | Body Mass Index | Hypoglycemic Agents - therapeutic use | Randomized Controlled Trials as Topic - statistics & numerical data | Risk Assessment | Sulfonylurea Compounds - therapeutic use | Thiazolidinediones - economics | Datasets as Topic - statistics & numerical data | Blood Glucose - drug effects | Cost-Benefit Analysis | Sex Factors | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | United Kingdom - epidemiology | Type 2 diabetes | Complications and side effects | Body mass index | Analysis | Clinical trials | Research | Hypoglycemic sulfonylureas | Sulfonylurea compounds | Thiazolidinediones | Risk factors | Edema | Therapy | Diabetes mellitus | Sex | Risk | Hypoglycemia | Males | Patients | Subgroups | Weight | Side effects | Reduction | Body mass | Sulfonylurea | Rosiglitazone | Genetics | Research design | Diabetes | Metformin | Females | Diabetes mellitus (non-insulin dependent) | Index Medicus
Journal Article
The journal of clinical endocrinology and metabolism, ISSN 0021-972X, 03/2020, Volume 105, Issue 6, pp. E2192 - E2206
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Prognosis | Blood Glucose - analysis | Follow-Up Studies | Glucagon-Like Peptide 1 - analogs & derivatives | Humans | Biomarkers - analysis | Diabetes Mellitus, Type 1 - pathology | Diabetes Mellitus, Type 1 - metabolism | Male | Diabetes Mellitus, Type 1 - drug therapy | Young Adult | Adolescent | Adult | Female | Incretins - therapeutic use | Glucagon-Like Peptide 1 - therapeutic use | Beta cells | Peptides | Titration | Diabetes mellitus (insulin dependent) | Diabetes | Pharmacokinetics | Diabetes mellitus (non-insulin dependent) | Bayesian analysis | Insulin | Index Medicus | Abridged Index Medicus
Journal Article
The American heart journal, ISSN 0002-8703, 09/2018, Volume 203, pp. 30 - 38
Type 2 diabetes | Medical research | Care and treatment | Chronic kidney failure | Patient outcomes | Cardiac patients | Clinical trials | Glycosylated hemoglobin | Medicine, Experimental | Glucose | Heart attack | Dextrose | Myocardial infarction | Heart | Glucagon | Drug development | Randomization | Atherosclerosis | Hemoglobin | Drug metabolism | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Glucagon-like peptide 1 | Cerebral infarction | Stroke | Enrollments | Diabetes mellitus | Coronary artery | Pancreatitis | Metabolism | Angina pectoris | Coronary artery disease | Disease control | Patients | Insulin | Arteriosclerosis | Infarction | Diabetes | Index Medicus | Abridged Index Medicus
Journal Article
European heart journal, ISSN 0195-668X, 2016, Volume 37, Issue 9, pp. 747 - 754
New therapies | Health technology assessment | Cardiovascular disease burden | Cardiovascular | Clinical trials | Drug development | Personalized medicine | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Drug Approval - economics | Clinical Trials as Topic - economics | Technology Assessment, Biomedical - economics | Cardiovascular Diseases - drug therapy | Drug Discovery - economics | Europe | Humans | Precision Medicine - economics | Cost of Illness | Interprofessional Relations | Data Collection | Drug Approval - legislation & jurisprudence | Societies, Medical | Drug Industry - economics | Costs and Cost Analysis - economics | Clinical Trials as Topic - standards | Therapies, Investigational - economics | Cardiovascular Diseases - economics | Index Medicus
Journal Article
Clinical pharmacology in drug development, ISSN 2160-763X, 05/2015, Volume 4, Issue 3, pp. 193 - 202
pharmacokinetics | Fabry disease | migalastat HCl | food effect | Migalastat HCl | Food effect | Pharmacokinetics | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | 1-Deoxynojirimycin - pharmacokinetics | Area Under Curve | Humans | Middle Aged | Half-Life | Biological Availability | Male | Metabolic Clearance Rate | Healthy Volunteers | Pharmaceutical Solutions | Young Adult | Capsules | Fasting - blood | Dietary Fats - administration & dosage | Postprandial Period | 1-Deoxynojirimycin - administration & dosage | Drug Compounding | 1-Deoxynojirimycin - analogs & derivatives | Adult | Female | 1-Deoxynojirimycin - adverse effects | Meals | Drug Administration Schedule | Administration, Oral | Food-Drug Interactions | 1-Deoxynojirimycin - blood | Cross-Over Studies | Texas | Adolescent | Aged | Therapeutic Equivalency | Bioavailability | Index Medicus
Journal Article
Clinical pharmacology in drug development, ISSN 2160-763X, 03/2015, Volume 4, Issue 3, pp. 193 - 202
Journal Article
European heart journal, ISSN 0195-668X, 03/2016, Volume 37, Issue 9, pp. 747 - 754
C-REACTIVE PROTEIN | New therapies | Health technology assessment | Cardiovascular | Clinical trials | SUBTILISIN/KEXIN TYPE 9 | MONOCLONAL-ANTIBODY | Drug development | Personalized medicine | KEY DATA ELEMENTS | Cardiovascular disease burden | HIGH-RISK | HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA | DOUBLE-BLIND | ASSOCIATION TASK-FORCE | PLACEBO-CONTROLLED TRIAL | CORONARY-HEART-DISEASE
Journal Article
European journal of heart failure, ISSN 1388-9842, 06/2017, Volume 19, Issue 6, pp. 718 - 727
Journal Article
Molecular genetics and metabolism, ISSN 1096-7192, 02/2013, Volume 108, Issue 2, pp. S70 - S70
Journal Article
PloS one, ISSN 1932-6203, 02/2014, Volume 9, Issue 2, pp. e89034 - e89034
1-Alkyl-2-acetylglycerophosphocholine Esterase - blood | Humans | Carotid Stenosis - drug therapy | Caspase 3 - metabolism | Caspase 8 - metabolism | Oximes - therapeutic use | Male | Dose-Response Relationship, Drug | Endarterectomy, Carotid | Plaque, Atherosclerotic - enzymology | Time Factors | Female | Benzaldehydes - therapeutic use | Plaque, Atherosclerotic - blood | Carotid Stenosis - surgery | Biomarkers - metabolism | Plaque, Atherosclerotic - surgery | Lysophosphatidylcholines - metabolism | Benzaldehydes - pharmacology | Gene Expression Regulation - drug effects | 1-Alkyl-2-acetylglycerophosphocholine Esterase - metabolism | Oximes - pharmacology | Aged | Carotid Stenosis - enzymology | Plaque, Atherosclerotic - drug therapy | Drugs | Plasma | Heart attacks | Lipids | Cardiovascular disease | Matrix metalloproteinase | Servers | Caspase-3 | Clinical outcomes | Lysophosphatidylcholine | Randomization | Databases | Java (programming language) | Atherosclerosis | HyperText Markup Language | Metalloproteinase | Safety | Pharmacodynamics | Phospholipase A2 | Caspase | Pharmacology | Gene expression | Low density lipoprotein | Caspase-8 | Phospholipase | Coronary vessels | Biomarkers | Acute coronary syndromes | Index Medicus | Data bases
Journal Article
The American heart journal, ISSN 0002-8703, 09/2018, Volume 203, pp. 30 - 38
Journal Article
Expert opinion on pharmacotherapy, ISSN 1465-6566, 04/2006, Volume 7, Issue 5, pp. 563 - 573
amiloride | potassium canrenoate | adrenal | aldosterone | eplerenone | primary aldosteronism | aldosterone blockade | primary hyperaldosteronism | mineralocorticoid receptor antagonist | hypertension | spironolactone | Hypertension | Amiloride | Eplerenone | Potassium canrenoate | Primary aldosteronism | Mineralocorticoid receptor antagonist | Spironolacrone | Adrenal | Aldosterone | Primary hyperaldosteronism | Aldosterone blockade | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Glucocorticoids - therapeutic use | Receptors, Mineralocorticoid - metabolism | Humans | Calcium Channel Blockers - therapeutic use | Hyperaldosteronism - complications | Sodium Channel Blockers - pharmacology | Clinical Trials as Topic | Hyperaldosteronism - metabolism | Calcium Channel Blockers - pharmacology | Hyperaldosteronism - drug therapy | Hypertension - etiology | Mineralocorticoid Receptor Antagonists - therapeutic use | Aldosterone - metabolism | Spironolactone - pharmacology | Amiloride - therapeutic use | Mineralocorticoid Receptor Antagonists - pharmacology | Amiloride - pharmacology | Glucocorticoids - pharmacology | Hypertension - prevention & control | Sodium Channel Blockers - therapeutic use | Drug Therapy, Combination | Spironolactone - therapeutic use | Practice Guidelines as Topic | Index Medicus
Journal Article